Clinical Trial Update: Determinants of Bladder Cancer Recurrence Study (The DETER Study)

View source ↗

Summary

The DETER Study, sponsored by Memorial Sloan Kettering Cancer Center, investigates determinants of bladder cancer recurrence and is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Bladder Cancer | Status: ACTIVE_NOT_RECRUITING